Aralez Bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $10M

  • Investors
  • 10

Aralez Bio General Information

Description

Developer of noncanonical amino acids designed to make products in a sustainable way. The company has invented an enzymatic method for synthesizing noncanonical amino acids (NCAA) also called unusual or unnatural amino acids and the proprietary approach allows NCAA to be synthesized with enantiopurity in a single step, enabling clients to access amino acids that are needed for innovations in pharmaceuticals, agriculture, and functional materials.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1933 Davis Street
  • Suite 235
  • San Leandro, CA 94577
  • United States
+1 (818)
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Other Pharmaceuticals and Biotechnology
Drug Discovery
Vertical(s)
Corporate Office
  • 1933 Davis Street
  • Suite 235
  • San Leandro, CA 94577
  • United States
+1 (818)

Aralez Bio Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aralez Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 01-Dec-2024 $10M Completed Generating Revenue
3. Seed Round 22-Aug-2022 Completed Generating Revenue
2. Grant 26-Jul-2019 $25K Completed Startup
1. Accelerator/Incubator 12-Jun-2019 Completed Startup
To view Aralez Bio’s complete valuation and funding history, request access »

Aralez Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed 4
Seed 3
Seed 2 2,131,286 $0.000100 $0.94 $0.94 1x $0.94 6.71%
Seed 1 2,277,812 $0.000100 $0.51 $0.51 1x $0.51 7.18%
To view Aralez Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aralez Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aralez Bio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fifty Years Venture Capital Minority
Spero Ventures Venture Capital Minority
Astia Venture Capital Minority
Climate Capital Venture Capital Minority
Freeflow Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Aralez Bio FAQs

  • When was Aralez Bio founded?

    Aralez Bio was founded in 2019.

  • Where is Aralez Bio headquartered?

    Aralez Bio is headquartered in San Leandro, CA.

  • What is the size of Aralez Bio?

    Aralez Bio has 22 total employees.

  • What industry is Aralez Bio in?

    Aralez Bio’s primary industry is Biotechnology.

  • Is Aralez Bio a private or public company?

    Aralez Bio is a Private company.

  • What is the current valuation of Aralez Bio?

    The current valuation of Aralez Bio is .

  • What is Aralez Bio’s current revenue?

    The current revenue for Aralez Bio is .

  • How much funding has Aralez Bio raised over time?

    Aralez Bio has raised $22M.

  • Who are Aralez Bio’s investors?

    Fifty Years, Spero Ventures, Astia, Climate Capital, and Freeflow Ventures are 5 of 10 investors who have invested in Aralez Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »